Mahusay, Reymond G.
HRN: 22-07-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2022
CEFUROXIME 750MG (VIAL)
10/19/2022
10/26/2022
IV
750mg
Q8h
Acute Gastritis With Mod Dhn; R/o Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes